Clin2
NCT02373280Possibly a fitRecruiting

7-day tailored treatment to clear H. pylori infection

Helicobacter Infection

Part of Infections clinical trials.

This trial tests whether a personalized 7-day treatment plan can fully get rid of H. pylori, a common stomach germ. It may help prevent ongoing stomach irritation and ulcers caused by the infection.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
600 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You have tested positive for H. pylori infection
  • You have not had H. pylori eradication treatment before
  • You have not taken certain medicines recently (antibiotics or bismuth in the last 4 weeks; PPIs in the last 2 weeks)
  • You do not have known advanced stomach cancer or other serious cancers
  • You do not have major liver or kidney problems, are not pregnant or breastfeeding, and have no allergy to the study drugs

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07115173Not yet recruiting· Phase 4
Triple therapy for h. pylori infection

This study tests a three-drug combination (called triple therapy) to get rid of H. pylori, a bacteria that can cause stomach problems like ulcers and inflammation. If you have H. pylori and one of the listed stomach conditions, this treatment might help clear the infection.

NCT07720037Not yet recruiting· Phase 4
Shorter high-dose treatment for H. pylori infection

This trial compares two short courses of medicine to get rid of an H. pylori stomach infection: a 10-day higher-dose treatment versus a 14-day standard-dose treatment. Both use two medicines (vonoprazan and amoxicillin) to see which works just as well with a shorter time frame.

NCT06200779Not yet recruiting· Phase 4
Personalized versus standard treatment for H. pylori infection

This study is testing whether giving H. pylori treatment based on the specific bacteria found in your stomach works better than the standard one-size-fits-all approach. If you are already getting an endoscopy with a biopsy, this trial could help find the most effective medication for your infection.

Porto, Porto District
NCT06731023Not yet recruiting
14-day treatment for hard-to-cure H. pylori infection

This study tests a 14-day treatment plan for people whose H. pylori infection has not been cured by previous treatments. The plan is guided by lab tests to choose the best antibiotics, which may increase the chance of clearing the infection.

Jinan, Shandong
NCT07405697Not yet recruiting· Phase 4
Personalized treatment for stubborn H. pylori infection

This study tests a new way to choose antibiotics for H. pylori infection when the usual treatment has failed. By looking at your stool sample, doctors can pick the medicine most likely to work for you.

Shanghai, Shanghai Municipality
NCT07232095Recruiting· Phase 4
7-Day treatment for H. pylori with new acid blocker and antibiotics

This trial tests a 7-day combination of vonoprazan, high-dose amoxicillin, and bismuth to treat Helicobacter pylori infection in people who have never been treated for it before. The goal is to see if this short course is effective and safe for curing the infection.

Nanjing, Jiangsu

Hear when a new Helicobacter Infection trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.